L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 4:04 pm Sale |
2023-12-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA |
L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% |
-5,814 (Position Closed) |
Filing |
| 2023-07-18 4:01 pm Purchase |
2023-06-26 | 13G | ZyVersa Therapeutics, Inc. ZVSA |
L1 Capital Global Opportunities Master Fund, Ltd. | 5,814 8.600% |
5,814 (New Position) |
Filing |